Medplus Health Services Limited — Important, 03-01-2025: General Updates
03-01-2025 | 07:22 pm
03-01-2025 | 07:22 pm
Optival Health Solutions Private Limited, a subsidiary of MedPlus Health Services, has faced a suspension of its Drug License for a store located in Mahal, Nagpur, Maharashtra, impacting its operations. This suspension, initiated by the Assistant Commissioner & Licensing Authority of the Food & Drug Administration, is set for a duration of 15 days, starting from the receipt of the order on January 2, 2025. The company estimates a potential revenue loss of approximately ₹9.45 crore due to this action. This situation is a noteworthy concern for MedPlus, and investors should monitor developments closely as it may influence operational stability and financial performance.
No comments yet. Be the first to comment!
